Shuyin Chen

A multicenter analysis of genomic profiles and PD-L1 expression of primary lymphoepithelioma-like carcinoma of the lung

N. Zhong, W. Feng, Shiyue Li, 2019, Modern Pathology.

A first case report of clinical response to targeted therapy in a patient with primary myoepithelial carcinoma of the lung harboring EGFR exon 19 deletion

Shiyue Li, Ming Liu, Chengzhi Zhou, 2020, Diagnostic Pathology.

Emergence of NOTCH2-NTRK1 After Osimertinib in a Patient With Lung Adenocarcinoma With Neuroendocrine Differentiation.

Yang-li Liu, Hui Li, Geng-peng Lin, 2021, Clinical lung cancer.

Combination therapy of first and third generation EGFR-TKIs for an advanced lung adenocarcinoma patient harboring EGFR mutations and amplification: a case report

Yongxing Chen, Shuyin Chen, Lirong Liu, 2020, Translational cancer research.

Integrated histological and molecular analyses of rebiopsy samples at osimertinib progression improve post-progression survivals: A single-center retrospective study.

Yi-long Wu, Jin-Ji Yang, Xuchao Zhang, 2020, Lung cancer.

Lung Adenocarcinoma Harboring Concomitant EGFR Mutations and BRAF V600E Responds to a Combination of Osimertinib and Vemurafenib to Overcome Osimertinib Resistance.

Jiexia Zhang, Chengzhi Zhou, A. Lizaso, 2020, Clinical lung cancer.

Temporal Heterogeneity of ROS1 Fusion and Braf Fusion Conferred Resistance to First-and Third-generation EGFR Tkis: a Case Report.

Liya Guan, Yihua Huang, Yuan Li, 2020 .